212
Participants
Start Date
January 1, 2024
Primary Completion Date
June 25, 2024
Study Completion Date
June 25, 2025
Oral semaglutide
Starting dose 3 mg for a month, followed by 7 mg for a month increased up to 14 mg a month
subcutaneous semaglutide
subcutaneous semaglutide can be started at 0,25 mg a week for a month, to be increased at 0,5 mg a week, up to 1 mg a week
Policlinico Paolo Giaccone, Palermo
University of Palermo
OTHER